Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial

Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial

Abstract Background Variation in de-adoption of ineffective or unsafe treatments is not well-understood. We examined de-adoption of erythropoiesis-stimulating agents (ESA) in anemia treatment among patients with chronic kidney disease (CKD) following new clinical evidence of harm and ineffectiveness...

Full description

Bibliographic Details
Main Authors: Khoa Vu, Jiani Zhou, Alexander Everhart, Nihar Desai, Jeph Herrin, Anupam B. Jena, Joseph S. Ross, Nilay D. Shah, Pinar Karaca-Mandic
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Nephrology
Subjects:
De-adoption
Physician prescribing
Medication utilization
Medical safety
Online Access:https://doi.org/10.1186/s12882-021-02491-y

Internet

https://doi.org/10.1186/s12882-021-02491-y

Similar Items